One of the biggest imaging OEMs is offering healthcare providers using its radiography systems a third party’s AI toolset for detecting lung abnormalities.
GE Healthcare announced the move June 18, stating the software uses commercially available algorithms developed and marketed by Korea-based Lunit as Insight CXR.
The technology, which gained CE certification last fall, automatically flags signs of eight deviations from the norm. These include COVID-19 and related pneumonias as well as TB, lung nodules, pleural effusions and other diagnoses.
Calling the product Thoracic Care Suite, GE says providers using its global fixed, mobile and radiography/fluoroscopy systems can implement the toolset without engaging in any enterprise IT projects.
GE says its collaboration with Lunit is one of the first team-ups it knows of to bring commercially available AI products from a medical AI startup to an existing x-ray OEM.
The announcement quotes a professor from the University of Oxford and comes less than a week after that institution announced a partnership with GE Healthcare. In that endeavor the organizations are using AI to predict disease severity in COVID patients.